

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * sensory perception of chemical stimulus (GO:0007606) | 8.99158714 |
| 2 | cellular response to dexamethasone stimulus (GO:0071549) | 8.78976758 |
| 3 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 8.49538873 |
| 4 | response to dexamethasone (GO:0071548) | 8.19513596 |
| 5 | dermatan sulfate biosynthetic process (GO:0030208) | 8.04078444 |
| 6 | gland morphogenesis (GO:0022612) | 7.79720333 |
| 7 | dermatan sulfate metabolic process (GO:0030205) | 7.76015435 |
| 8 | morphogenesis of an epithelial fold (GO:0060571) | 7.46920116 |
| 9 | cellular response to estradiol stimulus (GO:0071392) | 7.17385470 |
| 10 | chondroitin sulfate catabolic process (GO:0030207) | 7.05474262 |
| 11 | regulation of superoxide metabolic process (GO:0090322) | 6.92617475 |
| 12 | protein localization to cilium (GO:0061512) | 6.59393145 |
| 13 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 6.44895274 |
| 14 | cellular response to epidermal growth factor stimulus (GO:0071364) | 6.29561659 |
| 15 | digestive tract morphogenesis (GO:0048546) | 6.15063007 |
| 16 | ethanol oxidation (GO:0006069) | 6.12013198 |
| 17 | cellular glucuronidation (GO:0052695) | 5.71124954 |
| 18 | regulation of catenin import into nucleus (GO:0035412) | 5.55241069 |
| 19 | uronic acid metabolic process (GO:0006063) | 5.48421038 |
| 20 | glucuronate metabolic process (GO:0019585) | 5.48421038 |
| 21 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.34996807 |
| 22 | regulation of beta-amyloid formation (GO:1902003) | 5.30930011 |
| 23 | Notch signaling involved in heart development (GO:0061314) | 5.19586383 |
| 24 | one-carbon compound transport (GO:0019755) | 5.18680572 |
| 25 | response to epidermal growth factor (GO:0070849) | 5.10968894 |
| 26 | cellular response to estrogen stimulus (GO:0071391) | 5.04309438 |
| 27 | heart valve formation (GO:0003188) | 4.96224984 |
| 28 | cerebral cortex cell migration (GO:0021795) | 4.82378801 |
| 29 | hyperosmotic salinity response (GO:0042538) | 4.79343757 |
| 30 | embryonic placenta development (GO:0001892) | 4.74644574 |
| 31 | cellular response to ketone (GO:1901655) | 4.73904549 |
| 32 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.73630139 |
| 33 | astrocyte differentiation (GO:0048708) | 4.69956554 |
| 34 | ethanol metabolic process (GO:0006067) | 4.68798474 |
| 35 | antibacterial humoral response (GO:0019731) | 4.51886467 |
| 36 | positive regulation of digestive system process (GO:0060456) | 4.49808109 |
| 37 | epoxygenase P450 pathway (GO:0019373) | 4.49664190 |
| 38 | positive regulation of vasoconstriction (GO:0045907) | 4.47978658 |
| 39 | response to dietary excess (GO:0002021) | 4.41450919 |
| 40 | endocardial cushion morphogenesis (GO:0003203) | 4.39883260 |
| 41 | cellular response to glucocorticoid stimulus (GO:0071385) | 4.38690818 |
| 42 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.32017331 |
| 43 | flavonoid metabolic process (GO:0009812) | 4.30885462 |
| 44 | neuronal stem cell maintenance (GO:0097150) | 4.30875811 |
| 45 | positive regulation of vasodilation (GO:0045909) | 4.21135416 |
| 46 | antimicrobial humoral response (GO:0019730) | 4.19545047 |
| 47 | lateral ventricle development (GO:0021670) | 4.17198319 |
| 48 | cellular response to corticosteroid stimulus (GO:0071384) | 4.08443369 |
| 49 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 4.07838055 |
| 50 | tachykinin receptor signaling pathway (GO:0007217) | 3.99797741 |
| 51 | exogenous drug catabolic process (GO:0042738) | 3.85464483 |
| 52 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.85090832 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.79003177 |
| 54 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.78676671 |
| 55 | regulation of cholesterol metabolic process (GO:0090181) | 3.78009326 |
| 56 | telencephalon cell migration (GO:0022029) | 3.77244036 |
| 57 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.75912455 |
| 58 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.75638800 |
| 59 | activation of protein kinase A activity (GO:0034199) | 3.75598518 |
| 60 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.75135034 |
| 61 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.72876229 |
| 62 | hormone catabolic process (GO:0042447) | 3.69245865 |
| 63 | negative regulation of lipase activity (GO:0060192) | 3.67790730 |
| 64 | mating behavior (GO:0007617) | 3.67423109 |
| 65 | hair follicle development (GO:0001942) | 3.64498501 |
| 66 | positive regulation of DNA repair (GO:0045739) | 3.58552231 |
| 67 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.53720901 |
| 68 | coronary vasculature morphogenesis (GO:0060977) | 3.52186444 |
| 69 | mesenchyme morphogenesis (GO:0072132) | 3.51979847 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 3.47654019 |
| 71 | cGMP-mediated signaling (GO:0019934) | 3.47423259 |
| 72 | heart trabecula morphogenesis (GO:0061384) | 3.45350527 |
| 73 | regulation of nitric-oxide synthase activity (GO:0050999) | 3.43556851 |
| 74 | forebrain cell migration (GO:0021885) | 3.43378954 |
| 75 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.38179815 |
| 76 | alkaloid metabolic process (GO:0009820) | 3.38017272 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.37607191 |
| 78 | regulation of somitogenesis (GO:0014807) | 3.36633896 |
| 79 | drug catabolic process (GO:0042737) | 3.33684544 |
| 80 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.32993257 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.27598742 |
| 82 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.27251922 |
| 83 | gas transport (GO:0015669) | 3.22227149 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.21832515 |
| 85 | renal absorption (GO:0070293) | 3.19366718 |
| 86 | neuron projection regeneration (GO:0031102) | 3.16481987 |
| 87 | primary alcohol catabolic process (GO:0034310) | 3.14806060 |
| 88 | response to misfolded protein (GO:0051788) | 3.14381757 |
| 89 | regulation of cellular amide metabolic process (GO:0034248) | 3.11489492 |
| 90 | regulation of inclusion body assembly (GO:0090083) | 3.11013832 |
| 91 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.09112266 |
| 92 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.07234521 |
| 93 | cerebellar granule cell differentiation (GO:0021707) | 3.06725314 |
| 94 | cellular response to cholesterol (GO:0071397) | 3.03154985 |
| 95 | cardiac left ventricle morphogenesis (GO:0003214) | 3.00109020 |
| 96 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99810588 |
| 97 | regulation of sodium ion transport (GO:0002028) | 2.98870104 |
| 98 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.98740475 |
| 99 | axon ensheathment in central nervous system (GO:0032291) | 2.98590291 |
| 100 | central nervous system myelination (GO:0022010) | 2.98590291 |
| 101 | postsynaptic membrane organization (GO:0001941) | 2.98024990 |
| 102 | negative regulation of astrocyte differentiation (GO:0048712) | 2.96194384 |
| 103 | L-ascorbic acid metabolic process (GO:0019852) | 2.92198832 |
| 104 | omega-hydroxylase P450 pathway (GO:0097267) | 2.91001945 |
| 105 | negative regulation of myotube differentiation (GO:0010832) | 2.86793213 |
| 106 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.86438008 |
| 107 | positive regulation of astrocyte differentiation (GO:0048711) | 2.86346846 |
| 108 | L-phenylalanine catabolic process (GO:0006559) | 2.84062077 |
| 109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.84062077 |
| 110 | cellular potassium ion homeostasis (GO:0030007) | 2.84025767 |
| 111 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.83133297 |
| 112 | chemical homeostasis within a tissue (GO:0048875) | 2.82431037 |
| 113 | trabecula morphogenesis (GO:0061383) | 2.81900537 |
| 114 | phospholipid efflux (GO:0033700) | 2.80491198 |
| 115 | venous blood vessel morphogenesis (GO:0048845) | 2.80153750 |
| 116 | cardiac ventricle formation (GO:0003211) | 2.79587079 |
| 117 | protein insertion into membrane (GO:0051205) | 2.79390996 |
| 118 | hydrogen peroxide metabolic process (GO:0042743) | 2.78610404 |
| 119 | short-chain fatty acid metabolic process (GO:0046459) | 2.78363566 |
| 120 | mechanosensory behavior (GO:0007638) | 2.77451754 |
| 121 | ovulation cycle (GO:0042698) | 2.76645251 |
| 122 | response to vitamin A (GO:0033189) | 2.75341856 |
| 123 | atrioventricular valve morphogenesis (GO:0003181) | 2.75178616 |
| 124 | water transport (GO:0006833) | 2.74823175 |
| 125 | bile acid biosynthetic process (GO:0006699) | 2.74354530 |
| 126 | regulation of extracellular matrix organization (GO:1903053) | 2.74012768 |
| 127 | relaxation of cardiac muscle (GO:0055119) | 2.73783076 |
| 128 | astrocyte development (GO:0014002) | 2.73579225 |
| 129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.72679902 |
| 130 | amino-acid betaine metabolic process (GO:0006577) | 2.72397183 |
| 131 | carnitine metabolic process (GO:0009437) | 2.71998819 |
| 132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.71967208 |
| 133 | L-phenylalanine metabolic process (GO:0006558) | 2.71967208 |
| 134 | outer ear morphogenesis (GO:0042473) | 2.71259438 |
| 135 | regulation of glial cell proliferation (GO:0060251) | 2.71042652 |
| 136 | cell migration involved in heart development (GO:0060973) | 2.70658956 |
| 137 | negative regulation of myoblast differentiation (GO:0045662) | 2.69749559 |
| 138 | membrane repolarization during action potential (GO:0086011) | 2.67539092 |
| 139 | cardiac muscle cell proliferation (GO:0060038) | 2.67389156 |
| 140 | cAMP biosynthetic process (GO:0006171) | 2.67205547 |
| 141 | regulation of vasodilation (GO:0042312) | 2.65736830 |
| 142 | peripheral nervous system neuron development (GO:0048935) | 2.65543476 |
| 143 | response to gravity (GO:0009629) | 2.65398964 |
| 144 | cysteine metabolic process (GO:0006534) | 2.64047518 |
| 145 | positive regulation of steroid metabolic process (GO:0045940) | 2.62971095 |
| 146 | layer formation in cerebral cortex (GO:0021819) | 2.61800733 |
| 147 | high-density lipoprotein particle remodeling (GO:0034375) | 2.61785923 |
| 148 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.60616185 |
| 149 | alpha-linolenic acid metabolic process (GO:0036109) | 2.58558150 |
| 150 | protein localization to endosome (GO:0036010) | 2.58376582 |
| 151 | camera-type eye morphogenesis (GO:0048593) | 2.55500729 |
| 152 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.55411421 |
| 153 | cardiac conduction (GO:0061337) | 2.53278976 |
| 154 | toxin metabolic process (GO:0009404) | 2.52643420 |
| 155 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.51273476 |
| 156 | cellular copper ion homeostasis (GO:0006878) | 2.50216909 |
| 157 | positive regulation of hormone metabolic process (GO:0032352) | 2.48331361 |
| 158 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48307030 |
| 159 | protein carboxylation (GO:0018214) | 2.48307030 |
| 160 | negative regulation of sodium ion transport (GO:0010766) | 2.46925706 |
| 161 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.46038447 |
| 162 | regulation of fibrinolysis (GO:0051917) | 2.41984585 |
| 163 | fluid transport (GO:0042044) | 2.38254161 |
| 164 | regulation of cardioblast proliferation (GO:0003264) | 2.36041530 |
| 165 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.36041530 |
| 166 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.35169915 |
| 167 | ectoderm development (GO:0007398) | 2.35009715 |
| 168 | fatty acid oxidation (GO:0019395) | 2.34999897 |
| 169 | reverse cholesterol transport (GO:0043691) | 2.34822158 |
| 170 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.33513453 |
| 171 | peptide biosynthetic process (GO:0043043) | 2.32766944 |
| 172 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.30085632 |
| 173 | lipid oxidation (GO:0034440) | 2.29882336 |
| 174 | sodium ion export (GO:0071436) | 2.29540396 |
| 175 | positive regulation of glycolytic process (GO:0045821) | 2.29111884 |
| 176 | negative regulation of microtubule polymerization (GO:0031115) | 2.28385264 |
| 177 | dopamine receptor signaling pathway (GO:0007212) | 2.28093499 |
| 178 | cell communication involved in cardiac conduction (GO:0086065) | 2.28073224 |
| 179 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.26226653 |
| 180 | potassium ion homeostasis (GO:0055075) | 2.25036892 |
| 181 | behavioral response to cocaine (GO:0048148) | 2.23673265 |
| 182 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.22090353 |
| 183 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.21740315 |
| 184 | * sensory perception of smell (GO:0007608) | 17.0149875 |
| 185 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 15.0154319 |
| 186 | tongue development (GO:0043586) | 13.9990758 |
| 187 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 13.1943579 |
| 188 | regulation of phospholipase A2 activity (GO:0032429) | 13.1735391 |
| 189 | chemosensory behavior (GO:0007635) | 12.5949113 |
| 190 | regulation of superoxide anion generation (GO:0032928) | 11.2096041 |
| 191 | response to phenylpropanoid (GO:0080184) | 10.2067472 |
| 192 | positive regulation of catenin import into nucleus (GO:0035413) | 10.1957285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.43921992 |
| 2 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 5.09883252 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 4.56508224 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.23394517 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.81064064 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.80597997 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.52289889 |
| 8 | EGR1_19032775_ChIP-ChIP_M12_Human | 3.24930616 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.86937306 |
| 10 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.77817954 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.76588478 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72177163 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.60396771 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57154848 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.46166055 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40492235 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26810096 |
| 18 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 2.21334689 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.19662683 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19287554 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.18746624 |
| 22 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.18670449 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.08121137 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.05673758 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00757328 |
| 26 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90247608 |
| 27 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.80891386 |
| 28 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.80101349 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74916477 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74187818 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.74031222 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66713909 |
| 33 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.65985373 |
| 34 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.65144416 |
| 35 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64917771 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56790549 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54398824 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54073151 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53101233 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51861721 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51455646 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51455646 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50801179 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48855592 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48423987 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47963022 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47893955 |
| 48 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.40634710 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40499466 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38927574 |
| 51 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.37991894 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37982721 |
| 53 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37536215 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37105805 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.36808326 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35728695 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35186903 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33831213 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33406530 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31721260 |
| 61 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30654765 |
| 62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30603864 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30503188 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26197923 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.24626136 |
| 66 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24513322 |
| 67 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.24123754 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23907988 |
| 69 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.23684321 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23135869 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23003707 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22201071 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.20897757 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19991348 |
| 75 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.19470778 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19184596 |
| 77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18811072 |
| 78 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18518725 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17930844 |
| 80 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.17783573 |
| 81 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16520960 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15249607 |
| 83 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.15128639 |
| 84 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14160984 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13947613 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13874620 |
| 87 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.13801570 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12343243 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11592327 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11559923 |
| 91 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.11471342 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11206674 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06507631 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.06143922 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04080626 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02475327 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02289325 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01419077 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01364338 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01162575 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00632327 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99698162 |
| 103 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.99681182 |
| 104 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99429113 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98169765 |
| 106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97775545 |
| 107 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97479682 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96147156 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95826338 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95815809 |
| 111 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94304235 |
| 112 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.94170633 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94134166 |
| 114 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93727399 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93549826 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93327950 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92745749 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92258674 |
| 119 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.92119617 |
| 120 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.92054060 |
| 121 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92053088 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91592474 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90493188 |
| 124 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90124787 |
| 125 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89941483 |
| 126 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.87932671 |
| 127 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87524988 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86219880 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85928085 |
| 130 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.85917664 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85712986 |
| 132 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85677774 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85229852 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84379411 |
| 135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84341988 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84277549 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84277549 |
| 138 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83434052 |
| 139 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82894637 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82866636 |
| 141 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82336669 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82314674 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82048764 |
| 144 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.80918169 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80741337 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80405389 |
| 147 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80288564 |
| 148 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80178646 |
| 149 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79421202 |
| 150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78333342 |
| 151 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78235995 |
| 152 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.78132819 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77208200 |
| 154 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76904244 |
| 155 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76821614 |
| 156 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76770972 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.76744299 |
| 158 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.76677890 |
| 159 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.76598519 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76358422 |
| 161 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75200721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 6.06868396 |
| 2 | MP0005499_abnormal_olfactory_system | 5.98073953 |
| 3 | MP0005394_taste/olfaction_phenotype | 5.98073953 |
| 4 | MP0008789_abnormal_olfactory_epithelium | 4.54431815 |
| 5 | MP0000579_abnormal_nail_morphology | 4.49562947 |
| 6 | MP0000383_abnormal_hair_follicle | 3.93339660 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.21393956 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.14120524 |
| 9 | MP0005365_abnormal_bile_salt | 2.60958807 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.32825424 |
| 11 | MP0000467_abnormal_esophagus_morphology | 2.27316601 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.07178200 |
| 13 | MP0000427_abnormal_hair_cycle | 2.05259086 |
| 14 | MP0009379_abnormal_foot_pigmentation | 16.0029467 |
| 15 | MP0001984_abnormal_olfaction | 12.4754258 |
| 16 | MP0005360_urolithiasis | 1.88640521 |
| 17 | MP0006138_congestive_heart_failure | 1.78194588 |
| 18 | MP0003136_yellow_coat_color | 1.68807016 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.67148265 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.60379592 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.56383015 |
| 22 | MP0010030_abnormal_orbit_morphology | 1.55160364 |
| 23 | MP0001177_atelectasis | 1.53667629 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.49725583 |
| 25 | MP0002233_abnormal_nose_morphology | 1.45735334 |
| 26 | MP0002108_abnormal_muscle_morphology | 1.37192816 |
| 27 | MP0002098_abnormal_vibrissa_morphology | 1.33604258 |
| 28 | MP0003252_abnormal_bile_duct | 1.28526636 |
| 29 | MP0001346_abnormal_lacrimal_gland | 1.25835478 |
| 30 | MP0002060_abnormal_skin_morphology | 1.21318316 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.21201192 |
| 32 | MP0003329_amyloid_beta_deposits | 1.21094461 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.19117231 |
| 34 | MP0001881_abnormal_mammary_gland | 1.17659370 |
| 35 | MP0003091_abnormal_cell_migration | 1.14364126 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.12732717 |
| 37 | MP0003075_altered_response_to | 1.09057274 |
| 38 | MP0003115_abnormal_respiratory_system | 1.08515007 |
| 39 | MP0001664_abnormal_digestion | 1.01267048 |
| 40 | MP0000604_amyloidosis | 1.01003064 |
| 41 | MP0002822_catalepsy | 0.99440944 |
| 42 | MP0001853_heart_inflammation | 0.96775565 |
| 43 | MP0002177_abnormal_outer_ear | 0.96446606 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92487231 |
| 45 | MP0000613_abnormal_salivary_gland | 0.92345563 |
| 46 | MP0002896_abnormal_bone_mineralization | 0.91995092 |
| 47 | MP0003195_calcinosis | 0.91128146 |
| 48 | MP0005197_abnormal_uvea_morphology | 0.88214422 |
| 49 | MP0004043_abnormal_pH_regulation | 0.88186125 |
| 50 | MP0000377_abnormal_hair_follicle | 0.86267441 |
| 51 | MP0003566_abnormal_cell_adhesion | 0.86017018 |
| 52 | MP0002697_abnormal_eye_size | 0.82674516 |
| 53 | MP0005058_abnormal_lysosome_morphology | 0.82658029 |
| 54 | MP0002653_abnormal_ependyma_morphology | 0.80245366 |
| 55 | MP0001340_abnormal_eyelid_morphology | 0.79949756 |
| 56 | MP0000516_abnormal_urinary_system | 0.78763540 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 0.78763540 |
| 58 | MP0004381_abnormal_hair_follicle | 0.78269154 |
| 59 | MP0004858_abnormal_nervous_system | 0.77673691 |
| 60 | MP0002184_abnormal_innervation | 0.77408449 |
| 61 | MP0000609_abnormal_liver_physiology | 0.76905515 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.74419203 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 0.74240296 |
| 64 | MP0000534_abnormal_ureter_morphology | 0.73789354 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 0.72133640 |
| 66 | MP0005391_vision/eye_phenotype | 0.68728369 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 0.68193297 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 0.67942314 |
| 69 | MP0003300_gastrointestinal_ulcer | 0.67190923 |
| 70 | MP0001666_abnormal_nutrient_absorption | 0.66999551 |
| 71 | MP0005187_abnormal_penis_morphology | 0.66713642 |
| 72 | MP0005266_abnormal_metabolism | 0.66494058 |
| 73 | MP0005670_abnormal_white_adipose | 0.66343324 |
| 74 | MP0001502_abnormal_circadian_rhythm | 0.66313429 |
| 75 | MP0003632_abnormal_nervous_system | 0.65712498 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.64245997 |
| 77 | MP0004859_abnormal_synaptic_plasticity | 0.64163132 |
| 78 | MP0006054_spinal_hemorrhage | 0.63713315 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.63705340 |
| 80 | MP0009643_abnormal_urine_homeostasis | 0.63246586 |
| 81 | MP0003690_abnormal_glial_cell | 0.62832634 |
| 82 | MP0005388_respiratory_system_phenotype | 0.59475617 |
| 83 | MP0002133_abnormal_respiratory_system | 0.59475617 |
| 84 | MP0002063_abnormal_learning/memory/cond | 0.59137934 |
| 85 | MP0003633_abnormal_nervous_system | 0.58923202 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.58157531 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.57283789 |
| 88 | MP0001299_abnormal_eye_distance/ | 0.57262859 |
| 89 | MP0003635_abnormal_synaptic_transmissio | 0.56835983 |
| 90 | MP0003942_abnormal_urinary_system | 0.56042270 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.55399664 |
| 92 | MP0001542_abnormal_bone_strength | 0.55364626 |
| 93 | MP0004270_analgesia | 0.55210375 |
| 94 | MP0003938_abnormal_ear_development | 0.54473305 |
| 95 | MP0001849_ear_inflammation | 0.53182300 |
| 96 | MP0002970_abnormal_white_adipose | 0.50818753 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.50145459 |
| 98 | MP0003303_peritoneal_inflammation | 0.49850800 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.49642352 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.49591120 |
| 101 | MP0009840_abnormal_foam_cell | 0.49211723 |
| 102 | MP0008874_decreased_physiological_sensi | 0.48596741 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.48242605 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.48201687 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.48069930 |
| 106 | MP0003283_abnormal_digestive_organ | 0.45663390 |
| 107 | MP0002882_abnormal_neuron_morphology | 0.45613160 |
| 108 | MP0001286_abnormal_eye_development | 0.45459881 |
| 109 | MP0005332_abnormal_amino_acid | 0.44741868 |
| 110 | MP0004130_abnormal_muscle_cell | 0.44191777 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.43706288 |
| 112 | MP0004085_abnormal_heartbeat | 0.43410393 |
| 113 | MP0003755_abnormal_palate_morphology | 0.42648312 |
| 114 | MP0005508_abnormal_skeleton_morphology | 0.42208259 |
| 115 | MP0004885_abnormal_endolymph | 0.42201418 |
| 116 | MP0002928_abnormal_bile_duct | 0.42066061 |
| 117 | MP0000026_abnormal_inner_ear | 0.41939672 |
| 118 | MP0003186_abnormal_redox_activity | 0.41921642 |
| 119 | MP0009745_abnormal_behavioral_response | 0.41886831 |
| 120 | MP0005253_abnormal_eye_physiology | 0.41763087 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.41447122 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.41033275 |
| 123 | MP0005166_decreased_susceptibility_to | 0.40829479 |
| 124 | MP0004134_abnormal_chest_morphology | 0.40592055 |
| 125 | MP0008569_lethality_at_weaning | 0.39743671 |
| 126 | MP0009764_decreased_sensitivity_to | 0.39622417 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.39603320 |
| 128 | MP0006276_abnormal_autonomic_nervous | 0.39589589 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.38679538 |
| 130 | MP0005310_abnormal_salivary_gland | 0.38657976 |
| 131 | MP0001486_abnormal_startle_reflex | 0.38555680 |
| 132 | MP0000920_abnormal_myelination | 0.37883512 |
| 133 | MP0003935_abnormal_craniofacial_develop | 0.37861622 |
| 134 | MP0002092_abnormal_eye_morphology | 0.37581686 |
| 135 | MP0009053_abnormal_anal_canal | 0.37140280 |
| 136 | MP0004957_abnormal_blastocyst_morpholog | 0.36837699 |
| 137 | MP0000762_abnormal_tongue_morphology | 0.36813013 |
| 138 | MP0000778_abnormal_nervous_system | 0.36628032 |
| 139 | MP0003279_aneurysm | 0.35780675 |
| 140 | MP0001915_intracranial_hemorrhage | 0.35426113 |
| 141 | MP0002152_abnormal_brain_morphology | 0.35284566 |
| 142 | MP0002734_abnormal_mechanical_nocicepti | 0.35088321 |
| 143 | MP0003631_nervous_system_phenotype | 0.34841539 |
| 144 | MP0002009_preneoplasia | 0.34236463 |
| 145 | MP0000598_abnormal_liver_morphology | 0.34154797 |
| 146 | MP0003634_abnormal_glial_cell | 0.33975568 |
| 147 | MP0003183_abnormal_peptide_metabolism | 0.33079461 |
| 148 | MP0002064_seizures | 0.32923382 |
| 149 | MP0005645_abnormal_hypothalamus_physiol | 0.32625007 |
| 150 | MP0005376_homeostasis/metabolism_phenot | 0.31872761 |
| 151 | MP0001944_abnormal_pancreas_morphology | 0.31627316 |
| 152 | MP0000049_abnormal_middle_ear | 0.31391187 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.31224896 |
| 154 | MP0008961_abnormal_basal_metabolism | 0.31136651 |
| 155 | MP0004197_abnormal_fetal_growth/weight/ | 0.30735074 |
| 156 | MP0002116_abnormal_craniofacial_bone | 0.30134009 |
| 157 | MP0001905_abnormal_dopamine_level | 0.29503904 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.29248636 |
| 159 | MP0000163_abnormal_cartilage_morphology | 0.28790513 |
| 160 | MP0000432_abnormal_head_morphology | 0.28039891 |
| 161 | MP0001216_abnormal_epidermal_layer | 0.26803499 |
| 162 | MP0005409_darkened_coat_color | 0.24706807 |
| 163 | MP0005193_abnormal_anterior_eye | 0.24625856 |
| 164 | MP0003861_abnormal_nervous_system | 0.24575944 |
| 165 | MP0001191_abnormal_skin_condition | 0.23113567 |
| 166 | MP0001963_abnormal_hearing_physiology | 0.22336955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 5.72126834 |
| 2 | Elfin facies (HP:0004428) | 5.59784770 |
| 3 | Overriding aorta (HP:0002623) | 5.53220059 |
| 4 | Abnormality of dentin (HP:0010299) | 5.14425447 |
| 5 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.09482689 |
| 6 | Ulnar bowing (HP:0003031) | 4.93586077 |
| 7 | Obstructive sleep apnea (HP:0002870) | 4.84143634 |
| 8 | Abnormality of the diencephalon (HP:0010662) | 4.81393728 |
| 9 | Renovascular hypertension (HP:0100817) | 4.77530736 |
| 10 | Split foot (HP:0001839) | 4.72204397 |
| 11 | Insomnia (HP:0100785) | 4.61913961 |
| 12 | Decreased circulating renin level (HP:0003351) | 4.59790629 |
| 13 | Renal duplication (HP:0000075) | 4.42980540 |
| 14 | Flat cornea (HP:0007720) | 4.29352427 |
| 15 | Neoplasm of the lung (HP:0100526) | 4.22761915 |
| 16 | Mesangial abnormality (HP:0001966) | 4.19499796 |
| 17 | Bifid scrotum (HP:0000048) | 4.07190699 |
| 18 | Atrioventricular block (HP:0001678) | 3.96871552 |
| 19 | Humeroradial synostosis (HP:0003041) | 3.83602119 |
| 20 | Synostosis involving the elbow (HP:0003938) | 3.83602119 |
| 21 | Palpitations (HP:0001962) | 3.83493562 |
| 22 | Bronchomalacia (HP:0002780) | 3.82924259 |
| 23 | Neoplasm of the respiratory system (HP:0100606) | 3.71950179 |
| 24 | Deep venous thrombosis (HP:0002625) | 3.60664607 |
| 25 | Missing ribs (HP:0000921) | 3.60606936 |
| 26 | Urethral obstruction (HP:0000796) | 3.51958196 |
| 27 | Limb dystonia (HP:0002451) | 3.36928455 |
| 28 | Syncope (HP:0001279) | 3.28708224 |
| 29 | Megalocornea (HP:0000485) | 3.28113995 |
| 30 | Prolonged QT interval (HP:0001657) | 3.20045995 |
| 31 | Bladder diverticulum (HP:0000015) | 3.13114484 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.09906012 |
| 33 | Xanthomatosis (HP:0000991) | 3.04907577 |
| 34 | Abnormality of the right ventricle (HP:0001707) | 3.00848379 |
| 35 | Partial duplication of thumb phalanx (HP:0009944) | 3.00376911 |
| 36 | Torticollis (HP:0000473) | 2.99422438 |
| 37 | Bowing of the arm (HP:0006488) | 2.94780191 |
| 38 | Bowed forearm bones (HP:0003956) | 2.94780191 |
| 39 | Shallow orbits (HP:0000586) | 2.92164578 |
| 40 | Increased nuchal translucency (HP:0010880) | 2.91573192 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.91568943 |
| 42 | Poikilocytosis (HP:0004447) | 2.90867855 |
| 43 | Abnormality of the axillary hair (HP:0100134) | 2.89309853 |
| 44 | Abnormality of secondary sexual hair (HP:0009888) | 2.89309853 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.81508627 |
| 46 | Intestinal atresia (HP:0011100) | 2.80370031 |
| 47 | Increased circulating renin level (HP:0000848) | 2.78073060 |
| 48 | Dysphonia (HP:0001618) | 2.77279584 |
| 49 | Femoral bowing (HP:0002980) | 2.75697668 |
| 50 | Complement deficiency (HP:0004431) | 2.73308112 |
| 51 | Abnormality of sodium homeostasis (HP:0010931) | 2.72242230 |
| 52 | Late onset (HP:0003584) | 2.70572438 |
| 53 | Craniofacial dystonia (HP:0012179) | 2.69901923 |
| 54 | Lip pit (HP:0100267) | 2.69613628 |
| 55 | Choanal stenosis (HP:0000452) | 2.68782962 |
| 56 | Protrusio acetabuli (HP:0003179) | 2.64270277 |
| 57 | Partial duplication of the phalanx of hand (HP:0009999) | 2.60888946 |
| 58 | Patellar dislocation (HP:0002999) | 2.58619946 |
| 59 | Absent hand (HP:0004050) | 2.57518744 |
| 60 | Hyperlipoproteinemia (HP:0010980) | 2.57019977 |
| 61 | Hypobetalipoproteinemia (HP:0003563) | 2.56872107 |
| 62 | Vaginal fistula (HP:0004320) | 2.55744743 |
| 63 | Ketoacidosis (HP:0001993) | 2.55535421 |
| 64 | Atonic seizures (HP:0010819) | 2.55457089 |
| 65 | Hypercalcemia (HP:0003072) | 2.53821345 |
| 66 | Heart block (HP:0012722) | 2.53382040 |
| 67 | Adactyly (HP:0009776) | 2.52755926 |
| 68 | Turricephaly (HP:0000262) | 2.51471167 |
| 69 | Bowel diverticulosis (HP:0005222) | 2.50913481 |
| 70 | 11 pairs of ribs (HP:0000878) | 2.49267332 |
| 71 | Focal dystonia (HP:0004373) | 2.48732428 |
| 72 | Aplasia cutis congenita (HP:0001057) | 2.48454886 |
| 73 | Hyperaldosteronism (HP:0000859) | 2.46048740 |
| 74 | Abnormality of renin-angiotensin system (HP:0000847) | 2.45382033 |
| 75 | Hyperglycinemia (HP:0002154) | 2.45342778 |
| 76 | Labial hypoplasia (HP:0000066) | 2.44478327 |
| 77 | Ketosis (HP:0001946) | 2.43227761 |
| 78 | Delayed CNS myelination (HP:0002188) | 2.40964501 |
| 79 | Polycythemia (HP:0001901) | 2.39416048 |
| 80 | Abnormal atrioventricular conduction (HP:0005150) | 2.36680183 |
| 81 | Posterior embryotoxon (HP:0000627) | 2.35055224 |
| 82 | Abnormal EKG (HP:0003115) | 2.30480241 |
| 83 | Bowel incontinence (HP:0002607) | 2.29676760 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.29656840 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.29656840 |
| 86 | Tinnitus (HP:0000360) | 2.24981499 |
| 87 | Arterial tortuosity (HP:0005116) | 2.24929340 |
| 88 | Gastrointestinal atresia (HP:0002589) | 2.24230610 |
| 89 | Hyperparathyroidism (HP:0000843) | 2.23891860 |
| 90 | Laryngomalacia (HP:0001601) | 2.23813763 |
| 91 | Hyperglycinuria (HP:0003108) | 2.23803468 |
| 92 | Retinal dysplasia (HP:0007973) | 2.22874010 |
| 93 | Abnormality of the line of Schwalbe (HP:0008048) | 2.21345008 |
| 94 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.19662694 |
| 95 | Anosmia (HP:0000458) | 2.18161649 |
| 96 | Rectal fistula (HP:0100590) | 2.15185101 |
| 97 | Rectovaginal fistula (HP:0000143) | 2.15185101 |
| 98 | Cerebral inclusion bodies (HP:0100314) | 2.14960609 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.14548740 |
| 100 | Peripheral hypomyelination (HP:0007182) | 2.14340542 |
| 101 | Pointed chin (HP:0000307) | 2.12195443 |
| 102 | Hypothermia (HP:0002045) | 2.11968904 |
| 103 | Abnormality of the dental pulp (HP:0006479) | 2.11876411 |
| 104 | Sleep apnea (HP:0010535) | 2.10683769 |
| 105 | Abnormal large intestine physiology (HP:0012700) | 2.10448796 |
| 106 | Muscle fiber splitting (HP:0003555) | 2.10327227 |
| 107 | Broad metatarsal (HP:0001783) | 2.08659500 |
| 108 | Glossoptosis (HP:0000162) | 2.08622569 |
| 109 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08565990 |
| 110 | Hypolipoproteinemia (HP:0010981) | 2.08193848 |
| 111 | Abnormally folded helix (HP:0008544) | 2.06683168 |
| 112 | Hypoplastic female external genitalia (HP:0012815) | 2.06637714 |
| 113 | Abnormality of macular pigmentation (HP:0008002) | 2.04601279 |
| 114 | Spastic diplegia (HP:0001264) | 2.04481951 |
| 115 | Primary atrial arrhythmia (HP:0001692) | 2.04240409 |
| 116 | Absent toe (HP:0010760) | 2.04139873 |
| 117 | Wormian bones (HP:0002645) | 2.03926726 |
| 118 | Overfolded helix (HP:0000396) | 2.03867837 |
| 119 | Amyloidosis (HP:0011034) | 2.01866060 |
| 120 | Abnormality of cochlea (HP:0000375) | 2.01608068 |
| 121 | Vascular tortuosity (HP:0004948) | 2.01299798 |
| 122 | Alveolar cell carcinoma (HP:0006519) | 11.3563574 |
| 123 | Neoplasm of the tracheobronchial system (HP:0100552) | 10.4587698 |
| 124 | Overgrowth (HP:0001548) | 1.99966047 |
| 125 | Renal tubular acidosis (HP:0001947) | 1.99080143 |
| 126 | Hypoalphalipoproteinemia (HP:0003233) | 1.98350700 |
| 127 | Genetic anticipation (HP:0003743) | 1.97602569 |
| 128 | Right ventricular cardiomyopathy (HP:0011663) | 1.97545175 |
| 129 | Obsessive-compulsive behavior (HP:0000722) | 1.96521582 |
| 130 | Mutism (HP:0002300) | 1.96196433 |
| 131 | Hypercholesterolemia (HP:0003124) | 1.95139720 |
| 132 | Intestinal fistula (HP:0100819) | 1.93675877 |
| 133 | Hypercalciuria (HP:0002150) | 1.93479123 |
| 134 | Atrial fibrillation (HP:0005110) | 1.93120240 |
| 135 | Hypoplasia of the odontoid process (HP:0003311) | 1.92266102 |
| 136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91870985 |
| 137 | Arnold-Chiari malformation (HP:0002308) | 1.90800447 |
| 138 | Supraventricular tachycardia (HP:0004755) | 1.89729774 |
| 139 | Renal dysplasia (HP:0000110) | 1.89494016 |
| 140 | Abnormality of complement system (HP:0005339) | 1.89388778 |
| 141 | Hallux valgus (HP:0001822) | 1.89186402 |
| 142 | Adducted thumb (HP:0001181) | 1.88690305 |
| 143 | Prolonged partial thromboplastin time (HP:0003645) | 1.87822694 |
| 144 | Abnormal drinking behavior (HP:0030082) | 1.85894190 |
| 145 | Polydipsia (HP:0001959) | 1.85894190 |
| 146 | Precocious puberty (HP:0000826) | 1.85481213 |
| 147 | Supraventricular arrhythmia (HP:0005115) | 1.85427153 |
| 148 | Hyperammonemia (HP:0001987) | 1.85352010 |
| 149 | Anterior segment dysgenesis (HP:0007700) | 1.84237262 |
| 150 | Cerebral aneurysm (HP:0004944) | 1.82905343 |
| 151 | Neurofibrillary tangles (HP:0002185) | 1.81478260 |
| 152 | Hypokalemia (HP:0002900) | 1.79761616 |
| 153 | Neonatal onset (HP:0003623) | 1.79679143 |
| 154 | Spina bifida occulta (HP:0003298) | 1.79485199 |
| 155 | Hepatocellular carcinoma (HP:0001402) | 1.78121383 |
| 156 | Abnormality of the odontoid process (HP:0003310) | 1.76637788 |
| 157 | Polar cataract (HP:0010696) | 1.74854511 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.74674278 |
| 159 | Pulmonary embolism (HP:0002204) | 1.74296264 |
| 160 | Abnormality of the gastric mucosa (HP:0004295) | 1.73957817 |
| 161 | Fat malabsorption (HP:0002630) | 1.73472943 |
| 162 | Abnormal ciliary motility (HP:0012262) | 1.72703551 |
| 163 | Deviation of the hallux (HP:0010051) | 1.71860753 |
| 164 | Tarsal synostosis (HP:0008368) | 1.71286490 |
| 165 | Back pain (HP:0003418) | 1.70964034 |
| 166 | Epidermoid cyst (HP:0200040) | 1.70643997 |
| 167 | Esophageal varix (HP:0002040) | 1.69045733 |
| 168 | Polycystic kidney dysplasia (HP:0000113) | 1.68904527 |
| 169 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.68759310 |
| 170 | Periauricular skin pits (HP:0100277) | 1.68237850 |
| 171 | Preauricular pit (HP:0004467) | 1.68237850 |
| 172 | Morphological abnormality of the inner ear (HP:0011390) | 1.67371573 |
| 173 | Germ cell neoplasia (HP:0100728) | 1.66041261 |
| 174 | Periorbital edema (HP:0100539) | 1.65039698 |
| 175 | Bradycardia (HP:0001662) | 1.64861971 |
| 176 | Megalencephaly (HP:0001355) | 1.64260213 |
| 177 | Biliary tract neoplasm (HP:0100574) | 1.64252832 |
| 178 | Oligodactyly (hands) (HP:0001180) | 1.64005412 |
| 179 | Mitral valve prolapse (HP:0001634) | 1.62833692 |
| 180 | Portal hypertension (HP:0001409) | 1.62627548 |
| 181 | Osteolytic defects of the hand bones (HP:0009699) | 1.62441163 |
| 182 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62441163 |
| 183 | Death in childhood (HP:0003819) | 1.62275161 |
| 184 | Pulmonary artery stenosis (HP:0004415) | 1.60914783 |
| 185 | Abnormality of the endocardium (HP:0004306) | 1.60454174 |
| 186 | Generalized tonic-clonic seizures (HP:0002069) | 1.60250543 |
| 187 | Facial edema (HP:0000282) | 1.59860523 |
| 188 | Abnormal glucose tolerance (HP:0001952) | 1.59854746 |
| 189 | Hypercortisolism (HP:0001578) | 1.59841159 |
| 190 | Metabolic alkalosis (HP:0200114) | 1.59818610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN1 | 5.83080450 |
| 2 | MAPK11 | 4.03993441 |
| 3 | MAPK15 | 3.11676249 |
| 4 | SIK1 | 2.95697241 |
| 5 | RIPK1 | 2.87412300 |
| 6 | PAK3 | 2.85687307 |
| 7 | TYRO3 | 2.82574887 |
| 8 | LATS1 | 2.42324154 |
| 9 | STK39 | 2.39296770 |
| 10 | TRIB3 | 2.24558285 |
| 11 | CAMK2D | 2.07317240 |
| 12 | FRK | 2.06808332 |
| 13 | ERBB3 | 1.99067862 |
| 14 | DAPK2 | 1.98864408 |
| 15 | TGFBR2 | 1.95503160 |
| 16 | CAMK2B | 1.94432379 |
| 17 | SIK2 | 1.88845344 |
| 18 | HIPK2 | 1.88555296 |
| 19 | JAK2 | 1.85855322 |
| 20 | CSNK1A1L | 1.83009434 |
| 21 | NEK1 | 1.76562701 |
| 22 | LMTK2 | 1.75546692 |
| 23 | MAP3K2 | 1.75215686 |
| 24 | ERN1 | 1.68778847 |
| 25 | PKN2 | 1.68236594 |
| 26 | EEF2K | 1.62943957 |
| 27 | CAMK2G | 1.50598960 |
| 28 | MAP3K7 | 1.48719651 |
| 29 | DDR2 | 1.45849972 |
| 30 | FER | 1.44222523 |
| 31 | MAP2K4 | 1.44091173 |
| 32 | NTRK1 | 1.38390921 |
| 33 | MST1R | 1.36681678 |
| 34 | FGFR2 | 1.34286805 |
| 35 | CSNK1G2 | 1.31893436 |
| 36 | CSNK1G1 | 1.27715981 |
| 37 | GRK6 | 1.26800355 |
| 38 | PAK6 | 1.23091275 |
| 39 | CSNK1G3 | 1.17388084 |
| 40 | SCYL2 | 1.17013834 |
| 41 | BCKDK | 1.16482122 |
| 42 | MAP3K4 | 1.13597623 |
| 43 | INSRR | 1.11965333 |
| 44 | MAPKAPK3 | 1.11911023 |
| 45 | EPHB1 | 1.03920212 |
| 46 | NTRK2 | 1.03178444 |
| 47 | CDK6 | 1.02292475 |
| 48 | TESK1 | 1.01218187 |
| 49 | NTRK3 | 0.99772015 |
| 50 | OXSR1 | 0.99767065 |
| 51 | MAP2K1 | 0.94266463 |
| 52 | PDGFRA | 0.89752620 |
| 53 | ALK | 0.86358893 |
| 54 | PRKCG | 0.86328273 |
| 55 | PTK6 | 0.86203213 |
| 56 | EGFR | 0.84160525 |
| 57 | KSR2 | 0.83535350 |
| 58 | NEK6 | 0.82346712 |
| 59 | PRKD1 | 0.81724587 |
| 60 | PDK3 | 0.81659359 |
| 61 | PDK4 | 0.81659359 |
| 62 | MINK1 | 0.81534087 |
| 63 | TTN | 0.74182988 |
| 64 | PDPK1 | 0.72956522 |
| 65 | WNK4 | 0.71587595 |
| 66 | ERBB2 | 0.69625739 |
| 67 | PRKCH | 0.67752783 |
| 68 | ERBB4 | 0.67427964 |
| 69 | FGFR4 | 0.65618727 |
| 70 | STK24 | 0.64838270 |
| 71 | TTK | 0.63791528 |
| 72 | CAMKK1 | 0.63168792 |
| 73 | PRKG2 | 0.63071375 |
| 74 | RET | 0.62554297 |
| 75 | LRRK2 | 0.61745374 |
| 76 | DYRK1B | 0.59883564 |
| 77 | CAMK2A | 0.59882104 |
| 78 | TRPM7 | 0.59881337 |
| 79 | MET | 0.59459601 |
| 80 | CDK5 | 0.57729570 |
| 81 | ITK | 0.56551924 |
| 82 | ROCK2 | 0.55132543 |
| 83 | FYN | 0.54953915 |
| 84 | CSK | 0.54603632 |
| 85 | BMX | 0.53760469 |
| 86 | PAK2 | 0.50464483 |
| 87 | MAP3K10 | 0.50365207 |
| 88 | STK38L | 0.50063223 |
| 89 | ABL1 | 0.49209729 |
| 90 | PHKG2 | 0.48373399 |
| 91 | PHKG1 | 0.48373399 |
| 92 | RPS6KB2 | 0.47248822 |
| 93 | PTK2 | 0.46739974 |
| 94 | ICK | 0.46216524 |
| 95 | STK3 | 0.44933227 |
| 96 | WNK1 | 0.44450315 |
| 97 | PDK2 | 0.44145346 |
| 98 | FGFR3 | 0.43002865 |
| 99 | MARK1 | 0.42978787 |
| 100 | EPHA3 | 0.42324554 |
| 101 | JAK1 | 0.41990933 |
| 102 | PRKD3 | 0.41132619 |
| 103 | PRKACG | 0.40814911 |
| 104 | FES | 0.40522144 |
| 105 | PRKCD | 0.39785425 |
| 106 | NUAK1 | 0.38778942 |
| 107 | FGFR1 | 0.37672194 |
| 108 | PRKCZ | 0.37473983 |
| 109 | LIMK1 | 0.36759349 |
| 110 | DYRK2 | 0.36461489 |
| 111 | TYK2 | 0.34416345 |
| 112 | MAPK10 | 0.34247556 |
| 113 | TAOK1 | 0.33692715 |
| 114 | CSNK1E | 0.33571799 |
| 115 | ROCK1 | 0.31903093 |
| 116 | SMG1 | 0.31891737 |
| 117 | MARK2 | 0.30593270 |
| 118 | SGK2 | 0.29699432 |
| 119 | SIK3 | 0.29063967 |
| 120 | DYRK1A | 0.27113441 |
| 121 | UHMK1 | 0.27037239 |
| 122 | BLK | 0.26898266 |
| 123 | MAPK3 | 0.25988931 |
| 124 | SRC | 0.25222584 |
| 125 | MKNK2 | 0.24684696 |
| 126 | PDGFRB | 0.24580583 |
| 127 | RPS6KA5 | 0.22952615 |
| 128 | STK38 | 0.20581787 |
| 129 | SGK3 | 0.20485893 |
| 130 | PRKD2 | 0.19643444 |
| 131 | PRKDC | 0.19271886 |
| 132 | NME1 | 0.18759623 |
| 133 | PRKCB | 0.18578337 |
| 134 | CSF1R | 0.18509719 |
| 135 | SGK494 | 0.18115817 |
| 136 | SGK223 | 0.18115817 |
| 137 | MAPK12 | 0.17343085 |
| 138 | MAPK1 | 0.16996822 |
| 139 | PBK | 0.16740509 |
| 140 | SRPK1 | 0.15201512 |
| 141 | CDK3 | 0.14064714 |
| 142 | MTOR | 0.10885711 |
| 143 | MAPKAPK2 | 0.10872518 |
| 144 | MAPK14 | 0.10638149 |
| 145 | MAPK8 | 0.10474400 |
| 146 | CDK2 | 0.10309792 |
| 147 | IRAK1 | 0.10057631 |
| 148 | KIT | 0.08370970 |
| 149 | ABL2 | 0.08345384 |
| 150 | SGK1 | 0.08125181 |
| 151 | CSNK2A2 | 0.07960239 |
| 152 | FGR | 0.07665446 |
| 153 | CDK9 | 0.07544643 |
| 154 | PRKG1 | 0.07242216 |
| 155 | JAK3 | 0.06796457 |
| 156 | CLK1 | 0.06076123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 7.79231179 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 5.22360643 |
| 3 | Bladder cancer_Homo sapiens_hsa05219 | 3.86716440 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.63291158 |
| 5 | Endometrial cancer_Homo sapiens_hsa05213 | 3.56353847 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 3.48097743 |
| 7 | Notch signaling pathway_Homo sapiens_hsa04330 | 3.32993683 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.15049131 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.99855885 |
| 10 | Glioma_Homo sapiens_hsa05214 | 2.95451538 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.87273921 |
| 12 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.85665025 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.72453288 |
| 14 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.46170537 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.29462925 |
| 16 | Melanoma_Homo sapiens_hsa05218 | 2.22097204 |
| 17 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.13110811 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.09248844 |
| 19 | ErbB signaling pathway_Homo sapiens_hsa04012 | 2.08911129 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.04158433 |
| 21 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 2.00990416 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00127181 |
| 23 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.96651290 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95186175 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.93031850 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.88038008 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86265861 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83737906 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82765249 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82494545 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70740020 |
| 32 | Prostate cancer_Homo sapiens_hsa05215 | 1.68162709 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.66299431 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55859996 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.49169486 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46231160 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44922186 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44106317 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42724924 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.42278045 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.38117156 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.37146530 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34647717 |
| 44 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.34182804 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28870281 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28848311 |
| 47 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.27584109 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25335345 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22849990 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21292700 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20231585 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16439270 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.15096854 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06368180 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01530375 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98185746 |
| 57 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.97831038 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94890597 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94485502 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.88772188 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85318168 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.81946930 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81914488 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.81581260 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80868041 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79843092 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78538199 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77384656 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75474809 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73532873 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73485667 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71593160 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69588693 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68762499 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67419387 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67327614 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66543434 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.66499548 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66450769 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66114853 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65143330 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64643389 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63936996 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63655732 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62992295 |
| 86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61234229 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.61192337 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60951342 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60905656 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56368761 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.53910111 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53283268 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50252706 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49669861 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49408885 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49161319 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48817691 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48313339 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46546955 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45530377 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45462705 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45212758 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44517126 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43581585 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42087254 |
| 106 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41911663 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41741197 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41269469 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.40039225 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39574458 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | 0.39479622 |
| 112 | Taste transduction_Homo sapiens_hsa04742 | 0.38766556 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37151172 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36968686 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35650525 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.35582305 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35414891 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34804213 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33945738 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33064575 |
| 121 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32862132 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32048828 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.31770851 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31230519 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31145496 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30696298 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30599207 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30302264 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29870504 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28668003 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28665239 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27750718 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.27468374 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27296698 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27099792 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.27090341 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.25342783 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.23930716 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23243428 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23045052 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22914511 |
| 142 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22758116 |
| 143 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.22514352 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22273705 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.20992470 |
| 146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20968275 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.19657924 |
| 148 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18929725 |
| 149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.18797940 |
| 150 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16184168 |
| 151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11184863 |
| 152 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.10885792 |
| 153 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.10527907 |
| 154 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08446217 |
| 155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08312075 |

